Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features
暂无分享,去创建一个
Marie Loh | Pei Li Lim | Richie Soong | M. Loh | B. Iacopetta | R. Soong | F. Grieu | W. Yong | N. Liem | P. Ang | P. Lim | A. Vaithilingam | C. Platell | Pei Woon Ang | Barry Iacopetta | Wei Peng Yong | Cameron Platell | Fabienne Grieu | Natalia Liem | Aparna Vaithilingam
[1] M. Loda,et al. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. , 2006, The Journal of molecular diagnostics : JMD.
[2] Wei Jiang,et al. High-throughput DNA methylation profiling using universal bead arrays. , 2006, Genome research.
[3] R. Wolff,et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. , 2005, Gastroenterology.
[4] Ru-Fang Yeh,et al. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. , 2009, Carcinogenesis.
[5] M. Loda,et al. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. , 2007, The Journal of molecular diagnostics : JMD.
[6] R. Ward,et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. , 2002, Gastroenterology.
[7] Marina Bibikova,et al. A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms , 2009, PloS one.
[8] B. Iacopetta,et al. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands , 2002, Gut.
[9] D. Takai,et al. Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis , 2001, Oncogene.
[10] D. Ahlquist,et al. Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] N. Perrimon,et al. Specificities of heparan sulphate proteoglycans in developmental processes , 2000, Nature.
[12] P. Laird,et al. Epigenetic stem cell signature in cancer , 2007, Nature Genetics.
[13] J. Issa. CpG island methylator phenotype in cancer , 2004, Nature Reviews Cancer.
[14] Jian-Bing Fan,et al. GoldenGate assay for DNA methylation profiling. , 2009, Methods in molecular biology.
[15] B. Iacopetta,et al. Prognostic Significance of Microsatellite Instability and Ki-ras Mutation Type in Stage II Colorectal Cancer , 2003, Oncology.
[16] M. Kloor,et al. Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. , 2008, Gastroenterology.
[17] L. Hubert,et al. A general statistical framework for assessing categorical clustering in free recall. , 1976 .
[18] John Quackenbush,et al. Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample , 2008, PloS one.
[19] Randy D. Gascoyne,et al. Array-based DNA methylation profiling in follicular lymphoma , 2009, Leukemia.
[20] Kurt Berlin,et al. Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection , 2006, Nucleic acids research.
[21] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[22] P. Laird,et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.
[23] Jonathan Pevsner,et al. DNA methylation signatures within the human brain. , 2007, American journal of human genetics.
[24] N. Copeland,et al. Multiple Isoforms of Heparan Sulfate d-Glucosaminyl 3-O-Sulfotransferase , 1999, The Journal of Biological Chemistry.
[25] J. Jass. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.
[26] B. Iacopetta,et al. An improved quality control for bisulfite-PCR-based DNA methylation analysis: cycle threshold value , 2008, Clinical chemistry and laboratory medicine.
[27] N. Matsubara,et al. Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Megan F. Cole,et al. Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.
[29] Kimberly D Siegmund,et al. Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. , 2009, Human molecular genetics.
[30] N. Ahuja,et al. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] Miguel Alaminos,et al. A microarray-based DNA methylation study of glioblastoma multiforme , 2009, Epigenetics.
[32] B. Iacopetta,et al. Routine detection of the replication error phenotype in clinical tumor specimens using fluorescence-SSCP. , 2000, BioTechniques.
[33] B. Christensen,et al. Aging and Environmental Exposures Alter Tissue-Specific DNA Methylation Dependent upon CpG Island Context , 2009, PLoS genetics.
[34] M. Ferracin,et al. The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile , 2008, The Journal of pathology.
[35] P. Laurent-Puig,et al. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. , 2008, Cancer research.
[36] A. Serretti,et al. HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory , 2009, European Journal of Clinical Pharmacology.
[37] J. Ptak,et al. Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers , 2006, Human mutation.
[38] R. Wolff,et al. A Comparison of Colon and Rectal Somatic DNA Alterations , 2009, Diseases of the colon and rectum.
[39] J. Herman,et al. CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Ragoussis,et al. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma , 2009, Molecular Cancer.
[41] Minoru Toyota,et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer , 2007, Proceedings of the National Academy of Sciences.
[42] K. Kawakami,et al. BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status , 2006, Molecular Cancer.
[43] J. Meyerhardt,et al. CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci , 2008, Modern Pathology.
[44] Y. Yagi,et al. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers , 2003, Oncogene.
[45] M. Loda,et al. CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies , 2006, Gut.